You are here

layoffs

Pfizer Confirms to Cut Workforce by 2%

Pfizer Confirms to Cut Workforce by 2%

TheStreet.com

Flag link:

Drug giant Pfizer offers early retirement ahead of layoffs in memo to employees

Drug giant Pfizer offers early retirement ahead of layoffs in memo to employees

CNBC

Flag link:

Teva Postpones One Third of Israeli Layoffs Until 2019

Teva Postpones One Third of Israeli Layoffs Until 2019

Xtalks

Teva Pharmaceutical

drug manufacturing

Flag link:

Bayer Cutting More Than 200 Jobs in San Francisco Bay Area

Bayer Cutting More Than 200 Jobs in San Francisco Bay Area

Biopharma Dive

drug manufacturing

Flag link:

Vas Narasimhan, Novartis CEO, explains reasons behind 2,100 jobs cut

Vas Narasimhan, Novartis CEO, explains reasons behind 2,100 jobs cut

GoinPharma

Flag link:

On the heels of a global R&D reorganization, Novo Nordisk outlines 250 US job cuts

On the heels of a global R&D reorganization, Novo Nordisk outlines 250 US job cuts

Endpoints

Flag link:

Novartis to cut 2,200 jobs in Switzerland to boost profits

Novartis to cut 2,200 jobs in Switzerland to boost profits

Pharmaforum

Flag link:

Novo Nordisk to Lay off 400 to Focus on Innovation

Novo Nordisk to Lay off 400 to Focus on Innovation

BioSpace

Flag link:

After back-to-back trial flops, Realm slashes its staff, halts research work and ponders a fire sale

After back-to-back trial flops, Realm slashes its staff, halts research work and ponders a fire sale

Endpoints

Realm Therapeutics

atopic dermatitis

clinical trials

Flag link:

Roche CEO Severin Schwan is keeping his hand on the budget ax

Roche CEO Severin Schwan is keeping his hand on the budget ax

Endpoints

Flag link:

Takeda shuttering Chicago complex with 1,000 staffers in lead-up to Shire merger

Takeda shuttering Chicago complex with 1,000 staffers in lead-up to Shire merger

Endpoints

Flag link:

Akcea reducing workforce 10% following Waylivra rejection

Akcea reducing workforce 10% following Waylivra rejection

Biopharma Dive

Akcea Therapeutics

Flag link:

GlaxoSmithKline sharpens ax for 650 job cuts—450 in sales—to channel money toward new launches, R&D

GlaxoSmithKline sharpens ax for 650 job cuts—450 in sales—to channel money toward new launches, R&D

Fierce Pharma

Flag link:

New report re-ignites fresh buzz that Bayer is prepping an R&D overhaul and job cuts

New report re-ignites fresh buzz that Bayer is prepping an R&D overhaul and job cuts

Endpoints

Flag link:

GlaxoSmithKline whacks 165 jobs as it closes skincare products plant in Ireland

GlaxoSmithKline whacks 165 jobs as it closes skincare products plant in Ireland

Fierce Pharma

drug manufacturing

Flag link:

As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California

As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California

Fierce Pharma

Flag link:

Boston Scientific to Layoff 85 Massachusetts Workers by Year End

Boston Scientific to Layoff 85 Massachusetts Workers by Year End

Medical Devices and Diagnostics Industry

Boston Scientific

Flag link:

NewLink cuts 30% of staff to continue indoximod development

NewLink cuts 30% of staff to continue indoximod development

Biopharma Dive

NewLink Genetics

Flag link:

Achaogen Restructures & Slashes Staff 28% Ahead of Antibiotic Launch

Achaogen Restructures & Slashes Staff 28% Ahead of Antibiotic Launch

Xconomy

Flag link:

Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs

Novartis joins the Big Pharma exodus out of antibiotics, dumping research, cutting 140 and out-licensing programs

Endpoints

Flag link:

Pages